文献速递产科妇科

多囊卵巢综合征与产后抑郁症状:基于人群的队列研究

Polycystic ovary syndrome and postpartum depression symptoms: a population-based cohort study.
PubMed 文献 · Am J Obstet Gynecol · 2021-01-04

该研究基于美国犹他州妊娠风险评估监测系统2016-2018年3906名产后2-6个月女性的数据,发现临床多囊卵巢综合征与产后抑郁情绪或快感缺失的调整患病率比为1.76(95%CI 1.03-3.00),且产前抑郁和焦虑分别介导了20%和32%的效应。

要点

  • 临床多囊卵巢综合征与产后抑郁情绪或快感缺失风险升高相关(aPR=1.76,95%CI 1.03-3.00)。
  • 产前抑郁和焦虑分别介导20%和32%的多囊卵巢综合征对产后抑郁的效应。
  • 近20%报告至少2种多囊卵巢综合征症状的女性未获得临床诊断。

核心结论

  • 临床多囊卵巢综合征与产后抑郁情绪和症状相关,产前抑郁和焦虑介导该关联。

研究设计与样本

  • 基于人群的队列研究,纳入3906名产后2-6个月完成犹他州妊娠风险评估监测系统第8阶段问卷(2016-2018)的女性。

主要发现

  • 8.2%的女性报告临床多囊卵巢综合征,17.7%和23.5%报告产前抑郁和焦虑,9.5%和10.2%报告产后抑郁情绪和快感缺失。
  • 临床多囊卵巢综合征与产后抑郁情绪或快感缺失的调整患病率比为1.76(95%CI 1.03-3.00)。
  • 月经不规律和痤疮的调整患病率比为1.65(95%CI 1.13-2.41),月经不规律和多毛为1.40(95%CI 0.82-2.40),三者俱全为1.75(95%CI 0.96-3.19)。
  • 产前抑郁和焦虑分别介导20%和32%的临床多囊卵巢综合征对产后抑郁情绪和快感缺失的效应。

临床怎么用

  • 对多囊卵巢综合征女性应在产前进行心理筛查,以识别产后抑郁高风险者。
  • 注意近20%有至少2种多囊卵巢综合征症状的女性未获临床诊断,可能影响及时干预。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Women with polycystic ovary syndrome are more likely to experience several pregnancy complications including hypertensive disorders, gestational diabetes mellitus, and preterm births than women without polycystic ovary syndrome. However, at present, there is limited research on whether polycystic ovary syndrome is associated with both anxiety and depression during pregnancy and whether this augments a woman's risk of postpartum depression, particularly among high-risk populations who have limited access to care. OBJECTIVE: Our primary objective was to assess the association between prepregnancy polycystic ovary syndrome and postpartum depression, considering important baseline confounding factors. Our secondary objective was to evaluate the mediating role of prenatal depression and anxiety on the association between polycystic ovary syndrome and postpartum depression. STUDY DESIGN: This study involved a population-based sample of 3906 postpartum (2-6 months) women who completed the Utah Pregnancy Risk Assessment Monitoring System Phase 8 questionnaire (2016-2018). Weighted adjusted prevalence ratios were used to assess the association between polycystic ovary syndrome and postpartum depression, considering potential confounding factors and assessing mediating effects of depression and anxiety experienced during pregnancy. RESULTS: Following the exclusion criteria, 8.2% of women reported clinical polycystic ovary syndrome and 19.1%, 6.2%, and 4.4% reported irregular periods and acne, irregular periods and hirsutism, and all 3 symptoms, respectively. Moreover, 17.7% and 23.5% reported experiencing prenatal depression and anxiety and 9.5% and 10.2% reported experiencing postpartum depressed mood and anhedonia, respectively. Clinical polycystic ovary syndrome was associated with a 1.76 higher adjusted prevalence ratio (95% confidence interval, 1.03-3.00) for postpartum depressed mood or anhedonia after taking into consideration age, prepregnancy body mass index, race/ethnicity, education, and marital status. A similar higher prevalence was seen for irregular periods and acne (adjusted prevalence ratio, 1.65; 95% confidence interval, 1.13-2.41), irregular periods and hirsutism (adjusted prevalence ratio, 1.40; 95% confidence interval, 0.82-2.40), and all 3 symptoms (adjusted prevalence ratio, 1.75; 95% confidence interval, 0.96-3.19) and postpartum depressed mood or anhedonia. Prenatal depression and anxiety mediated 20% and 32% of the effect of clinical polycystic ovary syndrome on postpartum depressed mood and anhedonia, respectively. CONCLUSION: Clinical polycystic ovary syndrome is associated with postpartum depressed mood and symptoms among this population-based sample inclusive of high-risk mothers. Prenatal depression and anxiety mediate this association, emphasizing the importance of prenatal psychological screening among women with polycystic ovary syndrome. An additional important clinical and public health implication of this study lies in the finding that nearly 20% of women in this population-based sample who reported at least 2 polycystic ovary syndrome symptoms (including at-risk women who may not have access to care) had not received a clinical diagnosis for polycystic ovary syndrome.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Koric A, Singh B, VanDerslice JA, et al. Polycystic ovary syndrome and postpartum depression symptoms: a population-based cohort study. Am J Obstet Gynecol. 2021. PMID: 33412131. doi:10.1016/j.ajog.2020.12.1215

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。